欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6995/002
药品名称Meropenem Qilu 1 g Pulver zur Herstellung einer Injektions-/Infusionslösung
活性成分
    • meropenem trihydrate 1000.0 mg
剂型Powder for solution for injection/infusion
上市许可持有人QILU PHARMA SPAIN S.L. Paseo de la Castellana 40, planta 8, 28046 Madrid Spain
参考成员国 - 产品名称Germany (DE)
Meropenem Qilu 1000 mg Pulver zur Herstellung einer Injektions-/ Infusionslösung
互认成员国 - 产品名称
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
      Meropenem Qilu 1000 mg milteliai injekciniam ar infuziniam tirpalui
    • Estonia (EE)
    • Hungary (HU)
      Meropenem Qilu 1000 mg por oldatos injekcióhoz/infúzióhoz
    • Bulgaria (BG)
    • Denmark (DK)
    • Slovenia (SI)
    • France (FR)
    • Croatia (HR)
    • Spain (ES)
许可日期2022/11/16
最近更新日期2024/02/01
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase